fda d.i.s.c.o. burst edition: fda approval yescarta (axicabtagene ciloleucel) for adult patients ...
Published 5 months ago • 50 plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
3:01
fda d.i.s.c.o. burst edition: yescarta (axicabtagene ciloleucel) for adult patients with relapsed...
-
3:01
fda d.i.s.c.o. burst edition: fda approval of tibsovo (ivosidenib) for adult patients with previo...
-
4:01
fda d.i.s.c.o. burst edition: fda approval of tibsovo (ivosidenib) in combination with azacitidin...
-
3:01
fda d.i.s.c.o. burst edition: fda approval of ayvakit (avapritinib) for adult patients with advan...
-
7:01
fda d.i.s.c.o. burst edition: fda approvals of verzenio (abemaciclib) for adjuvant treatment of a...
-
4:01
fda d.i.s.c.o. burst edition: fda approves a new dosing regimen for asparaginase erwinia chrysant...
-
7:01
fda d.i.s.c.o. burst edition: fda approvals of tabrecta (capmatinib) for metastatic non-small cel...
-
6:01
fda d.i.s.c.o. burst edition: fda approvals of imbruvica (ibrutinib) for pediatric patients with ...
-
6:01
fda d.i.s.c.o.: osimertinib for non-small cell lung cancer
-
0:40
the recent fda approval of isavrd for transplant-ineligible newly diagnosed myeloma
-
0:36
guardant360® cdx receives fda approval
-
3:30
what does the fda want?
-
1:50
treating patients with poor-risk cytogenetics with venetoclax and hmas
-
14:16
cvi2018 session: innovative approaches to treat sfa, radial versus pedal? - ian cawich, md
-
3:03
venetoclax and 5-azacytidine for the treatment of mds and cmml
-
10:42
fda approvals of a biosimilar and dtc genetic test, breakthrough designation in mzl, and more
-
2:17
takeaways of dapa-hf: sglt2s for cvd
-
3:32
about fda’s data standards program